BR0111793A - Método para preparação de derivados de pirazolopirimidinona para o tratamento de impotência - Google Patents

Método para preparação de derivados de pirazolopirimidinona para o tratamento de impotência

Info

Publication number
BR0111793A
BR0111793A BR0111793-9A BRPI0111793A BR0111793A BR 0111793 A BR0111793 A BR 0111793A BR PI0111793 A BRPI0111793 A BR PI0111793A BR 0111793 A BR0111793 A BR 0111793A
Authority
BR
Brazil
Prior art keywords
treatment
impotence
preparing
derivatives
pharmaceutically acceptable
Prior art date
Application number
BR0111793-9A
Other languages
English (en)
Inventor
Moo-Hi Yoo
Won-Bae Kim
Min-Sun Chang
Soon-Hoe Kim
Dong-Sung Kim
Chul-Jun Bae
Yong-Duck Kim
Eun-Ha Kim
Original Assignee
Dong A Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd
Publication of BR0111793A publication Critical patent/BR0111793A/pt
Publication of BRPI0111793B1 publication Critical patent/BRPI0111793B1/pt
Publication of BRPI0111793B8 publication Critical patent/BRPI0111793B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MéTODO PARA PREPARAçãO DE DERIVADOS DE PIRAZOLO- PIRIMIDINONA PARA TRATAMENTO DE IMPOTêNCIA". A presente invenção se refere ao método para preparação de pirazolopirimidinona e seus sais farmaceuticamente aceitáveis tendo eficácia no tratamento de impotênica, uma das disfunções sexuais masculinas. O método de acordo com a presente invenção compreende as etapas de clorosulfonatação de pirazolamida, seguido por aminação com amina e ciclização intramolecular. O método provê derivados pirazolopirimidinona e seus sais farmaceuticamente aceitáveis com alto rendimento e de uma maneira económica.
BRPI0111793-9 2000-06-23 2001-05-18 método para preparação de derivados de pirazolopirimidinona para o tratamento de impotência BRPI0111793B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR2000/34966 2000-06-23
KR10-2000-0034966A KR100377782B1 (ko) 2000-06-23 2000-06-23 발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법
PCT/KR2001/000819 WO2001098304A1 (en) 2000-06-23 2001-05-18 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence

Publications (3)

Publication Number Publication Date
BR0111793A true BR0111793A (pt) 2003-05-27
BRPI0111793B1 BRPI0111793B1 (pt) 2019-07-16
BRPI0111793B8 BRPI0111793B8 (pt) 2021-05-25

Family

ID=36087864

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0111793-9 BRPI0111793B8 (pt) 2000-06-23 2001-05-18 método para preparação de derivados de pirazolopirimidinona para o tratamento de impotência

Country Status (19)

Country Link
US (1) US6844436B2 (pt)
EP (1) EP1299389B1 (pt)
JP (1) JP3939646B2 (pt)
KR (1) KR100377782B1 (pt)
CN (1) CN1217946C (pt)
AT (1) ATE341549T1 (pt)
AU (2) AU2001258896B2 (pt)
BR (1) BRPI0111793B8 (pt)
CA (1) CA2413761C (pt)
CY (1) CY1105769T1 (pt)
DE (1) DE60123616T2 (pt)
DK (1) DK1299389T3 (pt)
ES (1) ES2272475T3 (pt)
HK (1) HK1055732A1 (pt)
MX (1) MXPA02012420A (pt)
NZ (1) NZ523238A (pt)
PT (1) PT1299389E (pt)
RU (1) RU2236410C2 (pt)
WO (1) WO2001098304A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100377782B1 (ko) * 2000-06-23 2003-03-29 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법
CN100374441C (zh) 2003-06-06 2008-03-12 天津倍方科技发展有限公司 二氢吡咯[2,3-d]嘧啶-4-酮衍生物,其制备方法及其制药用途
EP1888074B1 (en) 2005-06-10 2011-12-21 Dong-A Pharmaceutical Co., Ltd. Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative
KR100963644B1 (ko) 2007-11-23 2010-06-15 한국과학기술연구원 피라졸로피리미딘온 유도체 및 그의 제조방법
CA3201054A1 (en) 2020-12-11 2022-06-16 Yoon-Suk Lee Novel compounds as androgen receptor and phosphodiesterase dual inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9119704D0 (en) 1991-09-14 1991-10-30 Pfizer Ltd Therapeutic agents
TR199902646T2 (xx) * 1997-04-25 2000-05-22 Pfizer Inc. Seks�el bozuklu�un tedavisi i�in pirazolopirimidinonlar.
GB9708831D0 (en) 1997-04-30 1997-06-25 Unilever Plc Suspensions with high storage stability, comprising an aqueous silicate solution and filler material
CA2342830C (en) * 1998-09-04 2008-11-25 Ortho-Mcneil Pharmaceutical, Inc. 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
EP1002798A1 (en) * 1998-11-20 2000-05-24 Orchid Chemicals & Pharmaceuticals Ltd. An improved process for preparing a therapeutically active pyrazolopyrimidinone derivative
KR100377782B1 (ko) * 2000-06-23 2003-03-29 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법

Also Published As

Publication number Publication date
EP1299389B1 (en) 2006-10-04
US6844436B2 (en) 2005-01-18
MXPA02012420A (es) 2004-02-26
US20030176696A1 (en) 2003-09-18
WO2001098304A1 (en) 2001-12-27
CA2413761A1 (en) 2001-12-27
PT1299389E (pt) 2006-12-29
JP2004501155A (ja) 2004-01-15
DK1299389T3 (da) 2007-02-05
BRPI0111793B1 (pt) 2019-07-16
JP3939646B2 (ja) 2007-07-04
ES2272475T3 (es) 2007-05-01
EP1299389A1 (en) 2003-04-09
NZ523238A (en) 2003-11-28
EP1299389A4 (en) 2005-02-02
HK1055732A1 (en) 2004-01-21
KR100377782B1 (ko) 2003-03-29
CN1441802A (zh) 2003-09-10
KR20020001041A (ko) 2002-01-09
RU2236410C2 (ru) 2004-09-20
CA2413761C (en) 2007-09-04
CN1217946C (zh) 2005-09-07
DE60123616T2 (de) 2007-01-18
CY1105769T1 (el) 2011-02-02
ATE341549T1 (de) 2006-10-15
DE60123616D1 (de) 2006-11-16
AU2001258896B2 (en) 2005-12-08
AU5889601A (en) 2002-01-02
BRPI0111793B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
LU92323I2 (fr) La combinaison de (a) dextromethorphan ou un de ses sels pharmaceutiquement acceptables, précursers ou dérivés, par ex. hydrobromure de dextromethorphan et en particulier hydrobromure de dextromethorphan monohydrate;et (b) quinidine ou un de ses selspharmacuetiquement acceptables, précurseurs ou dé rivés, par ex. sulfate de quinidine et en particulier sulfate de quinidine dihydrate
GEP20063783B (en) N-Phenpropylcyclopentyl-Substituted Glutaramide Derivatives as Inhibitors of Neutral Endopeptidase Enzyme (NEP) for Treating Female Sexual Dysfunction (FSAD)
EA200200337A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[4,3-d]ПИРИМИДИНА
WO2002050061A8 (en) Piperazine derivatives for treatment of bacterial infections
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
CY1106606T1 (el) Διϋδροξυπυριμιδινο καρβοξαμιδια αναστολεις της ιντεγκρασης του hiv
CY1107974T1 (el) Παραγωγα κινολινης και κιναζολινης εχοντα συναφεια προς τους υποδοχεις τυπου 5ht1
BRPI0315959B8 (pt) composto, composição farmacêutica, uso do composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso e processo para a preparação do composto
TR200003039T2 (tr) Seksüel fonksiyon bozukluklarının tedavisi için pirazolopirimidinon cGMP PDE5 inhibitörleri
EA200200249A1 (ru) Производные 3(5)-уреидопиразола, способ их получения и их применение в качестве противоопухолевых агентов
PL350456A1 (en) N−cyanomethylamides as protease inhibitors
GEP20053476B (en) 3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents
DK1525177T3 (da) Substituerede 1,3-diphenylprop-2-en-1-on-derivater, fremstilling og anvendelse deraf
BR0113291A (pt) steres de aporfina e seu uso em terapia
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
BR0115071A (pt) Usos de compostos de aminas heterocìclicas e de fenilazacicloalcano para tratamento de sìndrome de pernas inquietas (rls)
EE200200466A (et) 8,8a-dihürdroindeno[1,2-d]tiasooli derivaadid, mis on asendatud 8a-asendis, nende valmistamismeetodja kasutamine ravimitena, näiteks anorektiliste toimeainetena
NZ522368A (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
AR045016A1 (es) Derivados de 5-carbamimidoi-2-metilsulfaniltiofen-3-sulfonil como inhibidores conjugados de la cascada de complemento y su uso en el tratamiento de enfermedades.
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
WO2004002939A3 (en) Aminoalcohol derivatives
BRPI0415826A (pt) derivados de ceto-oxadiazol como inibidores de catepsina
BR0016043A (pt) Kit de partes, método para tratar trombose, uso de um antagonista de receptor p2t ou de um seu derivado farmaceuticamente aceitável, formulação farmacêutica, uso desta, processo para prepará-la, e, uso de um composto de fórmula ou de um seu derivado farmaceuticamente aceitável
BR0111793A (pt) Método para preparação de derivados de pirazolopirimidinona para o tratamento de impotência

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/07/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 22A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2724 DE 21-03-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.